Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Interleukin-6 sequence variants are not associated with prostate cancer risk.

Literature DB >> 15466986

Interleukin-6 sequence variants are not associated with prostate cancer risk.

Jielin Sun¹, Maria Hedelin, S Lilly Zheng, Hans-Olov Adami, Jeanette Bensen, Katarina Augustsson-Bälter, Baoli Chang, Jan Adolfsson, Tamara Adams, Aubrey Turner, Deborah A Meyers, William B Isaacs, Jianfeng Xu, Henrik Grönberg.

Abstract

Entities: Disease Gene

Mesh：

Substances：
Interleukin-6

Year: 2004 PMID： 15466986

Source DB: PubMed Journal: Cancer Epidemiol Biomarkers Prev ISSN： 1055-9965 Impact factor: 4.254

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

1. C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older.

Authors: Brandon L Pierce; Mary L Biggs; Marvalyn DeCambre; Alexander P Reiner; Christopher Li; Annette Fitzpatrick; Christopher S Carlson; Janet L Stanford; Melissa A Austin
Journal: Cancer Causes Control Date: 2009-03-08 Impact factor: 2.506

2. Polymorphisms in inflammatory genes, plasma antioxidants, and prostate cancer risk.

Authors: Jianjun Zhang; Ishwori B Dhakal; Nicholas P Lang; Fred F Kadlubar
Journal: Cancer Causes Control Date: 2010-04-30 Impact factor: 2.506

3. PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).

Authors: Laure Dossus; Rudolf Kaaks; Federico Canzian; Demetrius Albanes; Sonja I Berndt; Heiner Boeing; Julie Buring; Stephen J Chanock; Francoise Clavel-Chapelon; Heather Spencer Feigelson; John M Gaziano; Edward Giovannucci; Carlos Gonzalez; Christopher A Haiman; Göran Hallmans; Susan E Hankinson; Richard B Hayes; Brian E Henderson; Robert N Hoover; David J Hunter; Kay-Tee Khaw; Laurence N Kolonel; Peter Kraft; Jing Ma; Loic Le Marchand; Eiliv Lund; Petra H M Peeters; Meir Stampfer; Dan O Stram; Gilles Thomas; Michael J Thun; Anne Tjonneland; Dimitrios Trichopoulos; Rosario Tumino; Elio Riboli; Jarmo Virtamo; Stephanie J Weinstein; Meredith Yeager; Regina G Ziegler; David G Cox
Journal: Carcinogenesis Date: 2009-12-04 Impact factor: 4.944

4. Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality.

Authors: Jennifer Rider Stark; Haojie Li; Peter Kraft; Tobias Kurth; Edward L Giovannucci; Meir J Stampfer; Jing Ma; Lorelei A Mucci
Journal: Int J Cancer Date: 2009-06-01 Impact factor: 7.396

5. Interleukin-6 gene -174G>C and -636G>C promoter polymorphisms and prostate cancer risk.

Authors: J F Magalhães; A J Cortinhas; C M Albuquerque; C S Baptista; R Ribeiro; Carlos Viegas; Augusto Matos; João Machado; Maria A Pires; Henrique Guedes-Pinto; A Martins-Bessa; J C Leitão; E Bastos
Journal: Mol Biol Rep Date: 2012-10-17 Impact factor: 2.316

6. Association between interleukin-6 polymorphisms and urinary system cancer risk: evidence from a meta-analysis.

Authors: Kaiping Zhang; Li Zhang; Jun Zhou; Zongyao Hao; Song Fan; Cheng Yang; Chaozhao Liang
Journal: Onco Targets Ther Date: 2016-01-27 Impact factor: 4.147

7. Meta-analysis of the role of IL-6 rs1800795 polymorphism in the susceptibility to prostate cancer: Evidence based on 17 studies.

Authors: Tong-Zu Liu; Zhong-Qiang Guo; Ting Wang; Yue Cao; Di Huang; Xing-Huan Wang
Journal: Medicine (Baltimore) Date: 2017-03 Impact factor: 1.889